SX-682
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for SX-682, covering 2023-05-03 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]